2012 June | Neopharm Group

Sativex® receives regulatory approval in Israel

June 13, 2012

Neopharm Group and GW Pharmaceuticals plc announced that Sativex® (Delta-9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD) oromucosal spray) has received regulatory approval from the Israeli Ministry of Health for the treatment of spasticity and neuropathic pain due…

Promedico Receives “Best Employer” Honor from AKIM

Promedico, a part of Neopharm Group, received the “Best Employer” prize for 2012 for its employment program of mentally handicapped adults. The prize was presented at a special ceremony organized by AKIM and IKEA where…

Neopharm Receives Platinum Ratings in Maala CSR Index for 2012

Neopharm Group is proud to announce that it has received platinum ratings for its CSR (Corporate Social Responsibility) activities from Maala CSR Index, which is an index rating companies in CSR since 2003. The ratings…

Sativex® receives regulatory approval in Israel

Promedico Receives “Best Employer” Honor from AKIM

Neopharm Receives Platinum Ratings in Maala CSR Index for 2012

Group Companies